Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: A double-blind-placebo-controlled randomised trial


Aydogan M. , Eifan A. O. , Keles S., AKKOÇ T., Nursoy M. A. , Bahceciler N. N. , et al.

RESPIRATORY MEDICINE, cilt.107, ss.1322-1329, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 107 Konu: 9
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.rmed.2013.06.021
  • Dergi Adı: RESPIRATORY MEDICINE
  • Sayfa Sayısı: ss.1322-1329

Özet

Background: Although sublingual immunotherapy (SLIT) has been demonstrated to be a safe and efficient treatment in children with seasonal allergic rhinitis (AR), there is little evidence on the efficacy of SLIT with house-dust-mite (HDM) extract in children with isolated perennial AR.